SinoMab's IND Application of SM17 has once again Received Approval from NAMP Sep 12, 2023 09:48 HKT |  |
|
Q&M Dental Group Sets the Gold Standard for Best Investor Relations at Singapore Corporate Awards Sep 11, 2023 10:00 HKT |  |
|
UroViu Corporation Appoints Ali Amiri as New President and Chief Operating Officer Sep 06, 2023 21:00 HKT |  |
|
Malaysian Genomics Unveils Strategic Advances in Biopharmaceuticals Aug 29, 2023 13:00 HKT |  |
|
HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies Aug 28, 2023 19:30 HKT |  |
|
Sino Biopharmaceutical (1177.HK) Announces 2023 Interim Results Aug 25, 2023 19:12 HKT |  |
|
Hua Medicine Announces 2023 Interim Results Aug 25, 2023 18:20 HKT |  |
|
Universal Medical Announces 2023 Interim Results Aug 24, 2023 20:30 HKT |  |
|
Luzhu Biotechnology Announces 2023 Interim Results Aug 23, 2023 11:20 HKT |  |
|
The Personalized Lifestyle Medicine Institute Announces the 11th Annual Thought Leaders Consortium Aug 22, 2023 21:00 HKT |  |
|
WholisticResearch Reveals the Best Nootropics of 2023 Aug 18, 2023 06:00 HKT |  |
|
Asensus Surgical Continues to Spearhead Innovations and Growth in Surgical Robotics Aug 17, 2023 21:00 HKT |  |
|
New CGFNS Survey of Immigrant Nurses in the U.S. Reveals Their Economic Impact Aug 16, 2023 22:00 HKT |  |
|
Essex Bio-Technology Posts Sound 2023 Interim Financial Results, Revenue Up 37.1%, Profit Up 22% Aug 16, 2023 19:06 HKT |  |
|
AcroMeta's Laboratory Construction Business Rides on Singapore's Pandemic Readiness Strategy Aug 15, 2023 20:00 HKT |  |
|
Q&M 1H2023 Core Healthcare Revenue stays resilient as the Group focuses on organic growth plans Aug 15, 2023 10:00 HKT |  |
|
SinoMab Announces that IND Application of SM17 for the Treatment of Asthma was Approved by NAMP Aug 14, 2023 21:10 HKT |  |
|
iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory Technology Aug 01, 2023 20:00 HKT |  |
|
Exploring New Collaborative Opportunities! The Indonesia-China Healthcare and Biotech Investment Forum Successfully Held Jul 31, 2023 19:48 HKT |  |
|
Peptomyc Announces the Approval of Its Phase 1b Trial Testing OMO-103 in Combination With Standard of Care in PDAC Patients Jul 28, 2023 06:00 HKT |  |
|